Loading company…
Teon Therapeutics develops oral cancer therapies intended to restore immune responses against tumors.
Based in Redwood City, US, Teon Therapeutics develops oral cancer treatments that target metabolic signaling pathways and aim to restore anti-tumor immunity. Its founders are Elfatih Elzein, Lina Yao and Peter Fan. In February 2021, the company raised USD 30 mn in Series A funding led by Oceanpine Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in